BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 27028937)

  • 1. Sensitivities and utility of non-invasive serological tests in the diagnosis of bullous pemphigoid.
    Yew YW; Tey HL
    Int J Dermatol; 2016 Sep; 55(9):e510-1. PubMed ID: 27028937
    [No Abstract]   [Full Text] [Related]  

  • 2. Anti-desmogleins autoantibodies detected by ELISA and blotting in bullous pemphigoid: what do they mean?
    Julio T; Vernal S; Turatti A; Roselino AM
    Int J Dermatol; 2018 Jan; 57(1):124-127. PubMed ID: 29152717
    [No Abstract]   [Full Text] [Related]  

  • 3. Circulating bullous pemphigoid autoantibodies in the setting of negative direct immunofluorescence findings for bullous pemphigoid: A single-center retrospective review.
    Wang M; Lehman JS; Camilleri MJ; Drage LA; Wieland CN
    J Am Acad Dermatol; 2019 Aug; 81(2):472-479. PubMed ID: 30928465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoantibody serum levels and intensity of pruritus in bullous pemphigoid.
    Bardazzi F; Barisani A; Magnano M; Tengattini V; La Placa M; Patrizi A; Balestri R
    Eur J Dermatol; 2016 Aug; 26(4):390-1. PubMed ID: 27210833
    [No Abstract]   [Full Text] [Related]  

  • 5. Elevated levels of circulating immunoglobulin E autoantibodies against BP180 and BP230 in an intractable case of bullous pemphigoid.
    Akasaka E; Hagiwara C; Takiyoshi N; Aizu T; Nakano H; Sawamura D; Ota T
    J Dermatol Sci; 2016 Oct; 84(1):110-113. PubMed ID: 27492811
    [No Abstract]   [Full Text] [Related]  

  • 6. Enzyme-linked immunosorbent assay for the combination of bullous pemphigoid antigens 1 and 2 in the diagnosis of bullous pemphigoid.
    Roussel A; Benichou J; Randriamanantany ZA; Gilbert D; Drenovska K; Houivet E; Tron F; Joly P
    Arch Dermatol; 2011 Mar; 147(3):293-8. PubMed ID: 21422336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
    Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
    J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and Clinical Response to Omalizumab in a Patient with Bullous Pemphigoid.
    Menzinger S; Kaya G; Schmidt E; Fontao L; Laffitte E
    Acta Derm Venereol; 2018 Feb; 98(2):284-286. PubMed ID: 29136264
    [No Abstract]   [Full Text] [Related]  

  • 9. Correlation of autoantibodies against BP180/BP230 in response to topical corticosteroids in patients with bullous pemphigoid.
    Schneiderbauer R; Martinache S; Engstner M; Enk AH; Hadaschik EN
    Dermatol Ther; 2016 Nov; 29(6):419-423. PubMed ID: 27550573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the combination of BP180-NC16a enzyme-linked immunosorbent assay and BP230 enzyme-linked immunosorbent assay in the diagnosis of bullous pemphigoid.
    Yang B; Wang C; Chen S; Chen X; Lu X; Tian H; Yu M; Zhang D; Shi Z; Zhou G; Zhang F
    Indian J Dermatol Venereol Leprol; 2012; 78(6):722-7. PubMed ID: 23075641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrence of autoantibodies to bullous pemphigoid antigens and desmoglein 3: analysis of pathogenic and nonpathogenic antibodies.
    Ono S; Tanioka M; Tanizaki H; Fujisawa A; Koga H; Hashimoto T; Kamiya K; Aoyama Y; Iwatsuki K; Miyachi Y
    Br J Dermatol; 2013 Jun; 168(6):1357-60. PubMed ID: 23738642
    [No Abstract]   [Full Text] [Related]  

  • 12. Bullous Pemphigoid and Neurologic Diseases: Toward a Specific Serologic Profile?
    Petrera MR; Tampoia M; Guida S; Abbracciavento L; Fumarulo R; Foti C
    Endocr Metab Immune Disord Drug Targets; 2018; 18(6):662-664. PubMed ID: 30062977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ELISA instead of indirect IF in patients with BP: Comment on "Usefulness of BP230 and BP180-NC16a enzyme-linked immunosorbent assays in the initial diagnosis of bullous pemphigoid".
    Chan LS
    Arch Dermatol; 2011 Mar; 147(3):291-2. PubMed ID: 21422335
    [No Abstract]   [Full Text] [Related]  

  • 14. Methotrexate is safe and efficient as long-term treatment for bullous pemphigoid.
    Delaumenie S; Assikar S; Prudhomme R; Matei I; Souyri N; Dalmay F; Bedane C
    Eur J Dermatol; 2019 Apr; 29(2):217-218. PubMed ID: 30734720
    [No Abstract]   [Full Text] [Related]  

  • 15. Role of BP180NC16a-enzyme-linked immunosorbent assay (ELISA) in the diagnosis of bullous pemphigoid in China.
    Feng S; Lin L; Jin P; Wu Q; Zhou W; Sang H; Shao C
    Int J Dermatol; 2008 Jan; 47(1):24-8. PubMed ID: 18173596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erythema Multiforme-Like Bullous Pemphigoid.
    Imbernón-Moya A; Aguilar A; Burgos F; Gallego MÁ
    Actas Dermosifiliogr; 2016 Oct; 107(8):689-91. PubMed ID: 27048923
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythema With Nonscarring, Tense Blister Formation Without Circulating Anti-BP180 Antibodies.
    Otake-Irie H; Dainichi T; Kabashima K
    JAMA Dermatol; 2017 Nov; 153(11):1185-1186. PubMed ID: 28636686
    [No Abstract]   [Full Text] [Related]  

  • 18. A case of pemphigoid vegetans with autoantibodies against both BP180 and BP230 antigens.
    Suda-Takayanagi T; Hara H; Ohyama B; Hashimoto T; Terui T
    J Am Acad Dermatol; 2011 Jan; 64(1):206-8. PubMed ID: 21167421
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of a new ELISA assay for detection of BP230 autoantibodies in bullous pemphigoid.
    Tampoia M; Lattanzi V; Zucano A; Villalta D; Filotico R; Fontana A; Vena GA; Di Serio F
    Ann N Y Acad Sci; 2009 Sep; 1173():15-20. PubMed ID: 19758126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bullous pemphigoid in infancy with spontaneous remission.
    Nomura H; Funakoshi T; Baba A; Tanikawa A; Hayakawa K; Amagai M
    Eur J Dermatol; 2017 Feb; 27(1):95-96. PubMed ID: 27762214
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.